The role of oncology nurses and APPs in research is largely to stay abreast of trials that may be useful to patients and recommend them whenever possible, according to Erica Doubleday, MS, FNP-C, BSN, ...

Thomas E. Hutson, D.O., Pharm.D., Ph.D., chief of the Hematology Oncology Division in the Department of Internal Medicine at ...

Ten area providers have been elected to serve on the North Oaks Medical Center Medical Executive Committee for 2025.

Immune checkpoint inhibitors (ICIs), a major type of cancer immunotherapy, don't do much for hospitalized cancer patients, ...

New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

The Division of Hematology/Oncology provides a full range of inpatient and outpatient services for children and adolescents with malignancies and blood disorders. The Division of Pediatric ...

Nebraska Hematology-Oncology announced a new leader following the retirement of the company’s first CEO. Lisa Jansen, who has a background at Nebraska Medicine, was appointed as the organization ...

Patients with myelodysplastic syndromes (MDS) who undergo allogeneic hematopoietic stem cell transplantation (allo-HSCT) are older and face worse outcomes compared with non-MDS patients, according ...

Hematology-Oncology Associates of CNY has appointed Jennifer Pichoske as chief executive officer effective February 15, 2025. She succeeds Maryann Roefaro who was CEO since 2002 and is retiring.

Belinda R. Avalos, MD, is the American Society of Hematology 2025 president, and is a professor of medicine and a senior advisor to the president of Atrium Health Levine Cancer.